Compare VIR & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ERII |
|---|---|---|
| Founded | 2016 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.0M | 740.3M |
| IPO Year | 2019 | 2008 |
| Metric | VIR | ERII |
|---|---|---|
| Price | $6.00 | $13.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $25.73 | $16.50 |
| AVG Volume (30 Days) | ★ 2.0M | 433.6K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.56 |
| EPS | N/A | ★ 0.36 |
| Revenue | $16,860,000.00 | ★ $135,191,000.00 |
| Revenue This Year | N/A | $5.93 |
| Revenue Next Year | $46.25 | $8.97 |
| P/E Ratio | ★ N/A | $38.92 |
| Revenue Growth | N/A | ★ 0.10 |
| 52 Week Low | $4.16 | $10.86 |
| 52 Week High | $14.45 | $18.32 |
| Indicator | VIR | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 40.50 |
| Support Level | $5.73 | $13.68 |
| Resistance Level | $6.16 | $14.11 |
| Average True Range (ATR) | 0.36 | 0.35 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 22.93 | 12.60 |
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.